PE20120794A1 - Monohidrato cristalino de 3-{(s)-1-[4-(1-ciclopropil-2-oxo-1,2-dihidropiridin-4-il)fenil]etil}-(s)-6-(2-hidroxi-2-metilpropil)-6-fenil-[1,3]oxazinan-2-ona - Google Patents

Monohidrato cristalino de 3-{(s)-1-[4-(1-ciclopropil-2-oxo-1,2-dihidropiridin-4-il)fenil]etil}-(s)-6-(2-hidroxi-2-metilpropil)-6-fenil-[1,3]oxazinan-2-ona

Info

Publication number
PE20120794A1
PE20120794A1 PE2011001866A PE2011001866A PE20120794A1 PE 20120794 A1 PE20120794 A1 PE 20120794A1 PE 2011001866 A PE2011001866 A PE 2011001866A PE 2011001866 A PE2011001866 A PE 2011001866A PE 20120794 A1 PE20120794 A1 PE 20120794A1
Authority
PE
Peru
Prior art keywords
phenyl
ethyl
oxazinan
methylpropyl
oxo
Prior art date
Application number
PE2011001866A
Other languages
English (en)
Spanish (es)
Inventor
Martin Renz
Martin Schuele
Zhenrong Xu
Original Assignee
Vitae Pharmaceuticals Inc
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45478607&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20120794(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2009/002653 external-priority patent/WO2009134400A1/en
Priority claimed from PCT/US2009/004261 external-priority patent/WO2010011314A1/en
Application filed by Vitae Pharmaceuticals Inc, Boehringer Ingelheim Int filed Critical Vitae Pharmaceuticals Inc
Publication of PE20120794A1 publication Critical patent/PE20120794A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
PE2011001866A 2009-04-30 2010-04-30 Monohidrato cristalino de 3-{(s)-1-[4-(1-ciclopropil-2-oxo-1,2-dihidropiridin-4-il)fenil]etil}-(s)-6-(2-hidroxi-2-metilpropil)-6-fenil-[1,3]oxazinan-2-ona PE20120794A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2009/002653 WO2009134400A1 (en) 2008-05-01 2009-04-30 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
PCT/US2009/004261 WO2010011314A1 (en) 2008-07-25 2009-07-23 Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1

Publications (1)

Publication Number Publication Date
PE20120794A1 true PE20120794A1 (es) 2012-07-26

Family

ID=45478607

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2011001866A PE20120794A1 (es) 2009-04-30 2010-04-30 Monohidrato cristalino de 3-{(s)-1-[4-(1-ciclopropil-2-oxo-1,2-dihidropiridin-4-il)fenil]etil}-(s)-6-(2-hidroxi-2-metilpropil)-6-fenil-[1,3]oxazinan-2-ona

Country Status (10)

Country Link
JP (1) JP5784006B2 (ja)
AP (1) AP2011005948A0 (ja)
CL (1) CL2014001815A1 (ja)
CO (1) CO6501139A2 (ja)
HK (1) HK1169409A1 (ja)
IL (1) IL215249A (ja)
MX (1) MX2011011503A (ja)
NZ (1) NZ595473A (ja)
PE (1) PE20120794A1 (ja)
TN (1) TN2010000467A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2744946A1 (en) * 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2183228B1 (en) * 2007-07-26 2014-08-20 Vitae Pharmaceuticals, Inc. CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1

Also Published As

Publication number Publication date
MX2011011503A (es) 2011-11-18
CO6501139A2 (es) 2012-08-15
IL215249A0 (en) 2011-12-29
CL2014001815A1 (es) 2015-02-13
AP2011005948A0 (en) 2011-10-31
HK1169409A1 (en) 2013-01-25
NZ595473A (en) 2014-01-31
JP5784006B2 (ja) 2015-09-24
TN2010000467A1 (en) 2012-05-24
JP2012525440A (ja) 2012-10-22
IL215249A (en) 2014-12-31

Similar Documents

Publication Publication Date Title
PE20080890A1 (es) DERIVADOS DE IMIDAZOLONA E IMIDAZOLIDINONA COMO INHIBIDORES DE LA 11b-HSD1 PARA LA DIABETES
PE20090290A1 (es) Derivados de pirrolopiridina como inhibidores de bace
PE20110566A1 (es) Inhibidores ciclicos de 11beta-hidroxiesteroide deshidrogenasa 1
PE20080209A1 (es) Derivados de glicina como inhibidores de prolil hidroxilasa
PE20080927A1 (es) Derivados de benzoil-amino-heterociclilo como activadores de la glucoquinasa (glk)
PE20110063A1 (es) DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
PE20141361A1 (es) Compuesto heterociclico dihidroxi aromatico
MX339143B (es) Solvatos y complejos cristalinos de los derivados de (1s)-1,5-anhidro-1-c-(3-((fenil)metil)fenil)-d-glucitol con aminoacidos como inhibidores de sglt2 para el tratamiento de la diabetes.
PE20121510A1 (es) Isoquinolinonas y quinazolinonas sustituidas
PE20080895A1 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas
PE20090617A1 (es) Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa
PE20131377A1 (es) Triazina-oxadiazoles
PE20080362A1 (es) Derivados de ciclohexilpirazol-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1
PE20070004A1 (es) Imidazoquinolinas como inhibidores de quinasa de lipido
PE20090996A1 (es) Derivados de pirrolopirimidina como inhibidores de cinasa jak3
PE20070243A1 (es) Compuestos heterociclicos como inhibidores de la transcriptasa reversa de vih
PE20090649A1 (es) DERIVADOS DE PIRAZOL COMO INHIBIDORES DE LA ENZIMA 11ßHSD1
PE20080906A1 (es) Derivados heteroarilo como inhibidores de citocina
PE20090709A1 (es) Compuestos heterociclico de 5 miembros
PE20120911A1 (es) Derivados de prolina como inhibidores de catepsina
PE20051141A1 (es) Inhibidores de la polimerasa viral
PE20140703A1 (es) Derivados de heteroarilo como moduladores de nachr alfa 7
PE20110924A1 (es) Derivados de 2, 4-diamino-pirimidina n2, n4-disustituidos como inhibidores de jak3
PE20081845A1 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
PE20120356A1 (es) Compuestos para el tratamiento de trastornos metabolicos

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed